Harvey Investment Co. LLC Has $29.61 Million Holdings in Agilent Technologies, Inc. $A

Harvey Investment Co. LLC raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 2.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 230,732 shares of the medical research company’s stock after buying an additional 6,275 shares during the period. Agilent Technologies comprises 3.2% of Harvey Investment Co. LLC’s portfolio, making the stock its 11th biggest position. Harvey Investment Co. LLC owned about 0.08% of Agilent Technologies worth $29,614,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Wedmont Private Capital boosted its stake in Agilent Technologies by 2.3% in the third quarter. Wedmont Private Capital now owns 3,630 shares of the medical research company’s stock worth $503,000 after purchasing an additional 81 shares in the last quarter. waypoint wealth counsel lifted its position in Agilent Technologies by 4.3% during the 3rd quarter. waypoint wealth counsel now owns 1,984 shares of the medical research company’s stock worth $255,000 after buying an additional 82 shares in the last quarter. Verdence Capital Advisors LLC increased its position in Agilent Technologies by 5.0% in the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock valued at $215,000 after acquiring an additional 86 shares in the last quarter. M&T Bank Corp increased its position in Agilent Technologies by 0.4% in the 2nd quarter. M&T Bank Corp now owns 23,205 shares of the medical research company’s stock valued at $2,738,000 after acquiring an additional 86 shares in the last quarter. Finally, CENTRAL TRUST Co raised its stake in shares of Agilent Technologies by 3.7% in the second quarter. CENTRAL TRUST Co now owns 2,522 shares of the medical research company’s stock worth $298,000 after acquiring an additional 89 shares during the last quarter.

Insider Transactions at Agilent Technologies

In related news, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the sale, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the transaction, the chief executive officer directly owned 33,448 shares in the company, valued at approximately $5,017,200. This trade represents a 27.19% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Stock Up 1.3%

A stock opened at $137.82 on Monday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The stock has a market capitalization of $39.07 billion, a P/E ratio of 30.16, a P/E/G ratio of 4.00 and a beta of 1.29. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The business has a 50-day moving average of $144.41 and a 200-day moving average of $131.60.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.58 by $0.01. The firm had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The business’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s payout ratio is presently 21.66%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. The Goldman Sachs Group initiated coverage on shares of Agilent Technologies in a report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price target for the company. Rothschild & Co Redburn began coverage on Agilent Technologies in a research report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price objective for the company. Wells Fargo & Company upped their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. Finally, Bank of America increased their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a report on Tuesday, November 25th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $161.77.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.